90792-83-9Relevant articles and documents
ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR
-
Paragraph 001209-001210, (2021/11/13)
The present invention relates to compounds of formula I shown below: wherein R0, R1, R2, R3 and A are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a receptor activity is implicated, such as, for example, cancer.
AZA-BENZOFURANYL COMPOUNDS AND METHODS OF USE
-
Page/Page column 114, (2008/06/13)
The invention relates to azabenzofuranyl compounds of Formula (I) with anti-cancer and/or anti-inflammatory activity and more specifically to azabenzofuranyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS
-
Page 20, (2008/06/13)
-